[ad_1]
Swifties have to wait until next month to catch the filmed version of Taylor Swift’s Eras Tour in theaters, but AMC Entertainment Holdings Inc. is already basking in the afterglow of the film’s announcement.
The theater chain said Friday that it generated $26 million in advance-ticket-sales revenue from “Taylor Swift: The Eras Tour” on Thursday, the day the film was announced. That easily topped the prior record for one-day single-title ticket sales, with Swift’s movie dethroning “Spider-Man: No Way Home,” which raked in $16.9 million in its best showing on the metric.
See more: Taylor Swift’s Eras Tour is coming to movie theaters for under $20 a ticket
AMC
AMC,
also noted that it only took “Taylor Swift: The Eras Tour” three hours to break the record for first-day 24-hour ticket sales, which was also notched by “Spider-Man: No Way Home” in 2011.
The company plans to add additional showtimes to boost its capacity where necessary and possible. AMC has already promised four showtimes a day on Thursdays, Fridays, Saturdays and Sundays during the film’s run, which kicks off Oct. 13.
Adult tickets for standard showings will cost $19.89, a nod to Swift’s birth year and her “1989” album, while children and seniors will pay $13.13, a reference to Swift’s lucky number.
Although AMC expects to capitalize on the Swift mania, its stock has seen somewhat muted performance since Thursday’s film announcement. Shares shot up by as much as 9.2% in Thursday’s session but ended that day off 1.4%. They’re up 3.6% in Friday morning trading, reversing declines seen earlier in the session.
AMC shares are coming off their largest monthly percentage decline since the company went public in December 2013, falling 71% in the month of August.
Meanwhile, Cinemark Holdings Inc. shares
CNK,
were up 1.4% in Friday morning action, and Imax Corp.’s stock
IMAX,
was down fractionally.
[ad_2]
Source link
